Regional socioeconomic deprivation associated with the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes in Germany

Diabetes Obes Metab. 2024 Sep;26(9):4116-4120. doi: 10.1111/dom.15741. Epub 2024 Jul 9.
No abstract available

Keywords: GLP‐1RA; SGLT2 inhibitor; cardiovascular disease (CVD); diabetes; disparities; heart failure; kidney disease; socioeconomic factors.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Female
  • Germany / epidemiology
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Glucagon-Like Peptide-1 Receptor* / agonists
  • Humans
  • Hypoglycemic Agents* / adverse effects
  • Hypoglycemic Agents* / therapeutic use
  • Male
  • Middle Aged
  • Socioeconomic Factors
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Glucagon-Like Peptide-1 Receptor Agonists